{"DataElement":{"publicId":"3288249","version":"1","preferredName":"Bladder Cancer Last BCG Treatment  Year Number","preferredDefinition":"The number that represents the year in which the last BCG treatment for bladder cancer was given.","longName":"3288241v1.0:2896906v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3288241","version":"1","preferredName":"Bladder Cancer Last BCG Treatment  Administered","preferredDefinition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_Coming after all others in time or space or degree or being the only one remaining._A solution containing an attenuated, live culture preparation of the Bacillus Calmette Guerin (BCG) strain of Mycobacterium bovis with potential immunostimulating activity. Although the precise mechanism of action is unknown, upon intravesical administration, attenuated, live BCG bacteria in the solution come into direct contact with the bladder wall, inciting an antitumor granulomatous inflammatory reaction._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._The act of having given something (e.g., a medication or test).","longName":"2206697v1.0:3288239v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206697","version":"1","preferredName":"Bladder Malignant Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C12414:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0087-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3288239","version":"1","preferredName":"Last BCG Solution Therapeutic Procedure Administered","preferredDefinition":"Coming after all others in time or space or degree or being the only one remaining.:A solution containing an attenuated, live culture preparation of the Bacillus Calmette Guerin (BCG) strain of Mycobacterium bovis with potential immunostimulating activity. Although the precise mechanism of action is unknown, upon intravesical administration, attenuated, live BCG bacteria in the solution come into direct contact with the bladder wall, inciting an antitumor granulomatous inflammatory reaction.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:The act of having given something (e.g., a medication or test).","longName":"C25551:C83496:C49236:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Last","conceptCode":"C25551","definition":"Coming after all others in time or space or degree or being the only one remaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"BCG Solution","conceptCode":"C83496","definition":"A solution containing an attenuated, live culture preparation of the Bacillus Calmette Guerin (BCG) strain of Mycobacterium bovis with potential immunostimulating activity. Although the precise mechanism of action is unknown, upon intravesical administration, attenuated, live BCG bacteria in the solution come into direct contact with the bladder wall, inciting an antitumor granulomatous inflammatory reaction.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE79A48F-9299-525A-E040-BB89AD435406","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"ONEDATA","dateModified":"2011-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE79A48F-92AA-525A-E040-BB89AD435406","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2896906","version":"1","preferredName":"Event Year Number","preferredDefinition":"Event; something that happens at a given place and time._The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"EVT_YR_NUM","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"4","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"0","format":"YYYY ","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2896905","version":"1","preferredName":"Event Year Number","preferredDefinition":"Event; something that happens at a given place and time.:The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25499:C29848:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Event","conceptCode":"C25499","definition":"Something that happens at a given place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B61CDFC-6600-243E-E040-BB89AD43472E","latestVersionIndicator":"Yes","beginDate":"2009-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-02","modifiedBy":"ONEDATA","dateModified":"2009-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B61CDFC-6611-243E-E040-BB89AD43472E","latestVersionIndicator":"Yes","beginDate":"2009-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-02","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Year of Last BCG treatment","type":"Preferred Question Text","description":"Year of Last BCG treatment","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE79ABF0-8033-2571-E040-BB89AD430A80","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}